Expertise in
26
conditions

Dr. Viraj Master

Urology
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
Offers Telehealth
29 Years of Experience
Referral may be required
Expertise in
26
conditions
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 

Overview

Viraj Master is a Urologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 29 years.

Dr. Master is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Penile Cancer, Prostate Cancer, Nephrectomy, and Lymphadenectomy.

Dr. Master is board certified in American Board Of Urology, 2006. He is actively involved in clinical research, co-authoring 377 peer reviewed articles and participating in 6 clinical trials.

Graduate Institution

University Of Chicago, 1997.0

Residency

UCSF Medical Center

Specialties

Urology

Licenses

Urology in GA

Board Certifications

American Board Of Urology, 2006

Fellowships

UCSF Medical Center

Hospital Affiliations

Emory University Hospital Midtown
Emory University Hospital
Saint Joseph's Hospital Of Atlanta, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Emory Clinic at 1365 Clifton Road
1365 Clifton Road Northeast, BldgB, Atlanta, GA 30322

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 04, 2025
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
Investigation of Therapy Response With Amino Acid Analogue Transport PET Imaging
Investigation of Therapy Response With Amino Acid Analogue Transport PET Imaging
Enrollment Status: Completed
Publish Date: January 07, 2020
Intervention Type: Drug, Other
Study Phase: Phase 2
Targeted Fusion Biopsy of the Prostate
Targeted Fusion Biopsy of the Prostate
Enrollment Status: Completed
Publish Date: May 08, 2019
Intervention Type: Procedure, Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

376 Total Publications

Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422].
Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422].
Journal: Clinical genitourinary cancer
Published: March 18, 2026
Similar Doctors
Expertise in
37
conditions
Dr. Kenneth Ogan
Urology
Expertise in
37
conditions
Dr. Kenneth Ogan
Urology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (0.3 miles away)
404-778-4898
Experience:
31+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kenneth Ogan is a Urologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 31 years. Dr. Ogan is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Ureterocele, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Ureteroscopy. Dr. Ogan is board certified in American Board Of Urology, 2004.

Expertise in
14
conditions
Dr. Shreyas S. Joshi
Urology
Expertise in
14
conditions
Dr. Shreyas S. Joshi
Urology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (0.3 miles away)
404-778-4898
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Shreyas Joshi is a Urologist practicing medicine in Atlanta, Georgia. Dr. Joshi is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Prostatectomy.

Expertise in
10
conditions
Dr. Vikram M. Narayan
Urology
Expertise in
10
conditions
Dr. Vikram M. Narayan
Urology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (0.3 miles away)
404-778-4898
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Vikram Narayan is a Urologist practicing medicine in Atlanta, Georgia. Dr. Narayan is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Frequently Asked Questions about Dr. Viraj Master

How do I make an appointment with Dr. Viraj Master?

You can book an appointment with Dr. Viraj Master by calling their office at 404-778-4898. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Viraj Master a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Viraj Master is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Viraj Master specialize in?

While Dr. Viraj Master is a Urology, they have specific expertise in Renal Cell Carcinoma (RCC), Nephrectomy, and Penile Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Viraj Master participate in research or clinical trials?

Yes. Dr. Viraj Master has published 376 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Viraj Master's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Viraj Master accept my insurance?

Dr. Viraj Master accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 404-778-4898 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Master's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 12 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile